Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy

European Radiology

Volumn 19, Issue 3, 2009, Pages 770-778

  Cheikh, Alexandre Ben ^a,b,c   Girouin, Nicolas ^a,b,c   Colombel, Marc ^a   Maréchal, Jean Marie ^a   Gelet, Albert ^a,e   Bissery, Alvine ^c,d   Rabilloud, Muriel ^c,d   Lyonnet, Denis ^a,b,c,e   Rouviève, Olivier ^a,b,c,e  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e INSERM   (France)

Author keywords

Dynamic contrast enhanced MRI; MRI; Prostate biopsy; Prostate cancer

Indexed keywords

GADOTERATE MEGLUMINE; PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER LOCALIZATION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REPEAT PROCEDURE; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 59949087150     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-1190-8     Document Type: Article

References (45)

1. Hodge KK, McNeal JE, Terris MK et al (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71-74
2. Sadeghi-Nejad H, Simmons M, Dakwar G et al (2006) Controversies in transrectal ultrasonography and prostate biopsy. Ultrasound Q 22:169-175
3. Presti JC Jr., O'Dowd GJ, Miller MC et al (2003) Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 169:125-129
4. Gore JL, Shariat SF, Miles BJ et al (2001) Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 165:1554-1559
5. Scattoni V, Zlotta A, Montironi R et al (2007) Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: A critical analysis of the literature. Eur Urol 52:1309-1322
6. Levine MA, Ittman M, Melamed J et al (1998) Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159:471-475
7. Chang JJ, Shinohara K, Bhargava V et al (1998) Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 160:2111-2114
8. King CR, McNeal JE, Gill H et al (2004) Extended prostate biopsy scheme improves reliability of Gleason grading: Implications for radiotherapy patients. Int J Radiat Oncol Biol Phys 59:386-391
9. Singh H, Canto EI, Shariat SF et al (2004) Predictors of prostate cancer after initial negative systematic 12 core biopsy. J Urol 171:1850-1854
10. Mian BM, Naya Y, Okihara K et al (2002) Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology 60:836-840
11. Stewart CS, Leibovich BC, Weaver AL et al (2001) Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 166:86-91
12. Djavan B, Remzi M, Marberger M (2003) When to biopsy and when to stop biopsying. Urol Clin North Am 30:253-262 viii
13. Busby JE, Evans CP (2004) Determining variables for repeat prostate biopsy. Prostate Cancer Prostatic Dis 7:93-98
14. Park SJ, Miyake H, Hara I et al (2003) Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy. Int J Urol 10:68-71
15. Djavan B, Zlotta A, Remzi M et al (2000) Optimal predictors of prostate cancer on repeat prostate biopsy: A prospective study of 1,051 men. J Urol 163:1144-1148
16. Zackrisson B, Aus G, Lilja H et al (2003) Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. Eur Urol 43:327-332
17. Rouviere O, Hartman RP, Lyonnet D (2006) Prostate MR imaging at high-field strength: Evolution or revolution? Eur Radiol 16:276-284
18. Kirkham AP, Emberton M, Allen C (2006) How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 50:1163-1174
19. Girouin N, Mege-Lechevallier F, Tonina Senes A et al (2007) Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: Is it reasonable? Eur Radiol 17:1498-1509
20. Villers A, Puech P, Mouton D et al (2006) Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: Correlation with radical prostatectomy findings. J Urol 176:2432-2437
21. Kim JK, Hong SS, Choi YJ et al (2005) Wash-in rate on the basis of dynamic contrast-enhanced MRI: Usefulness for prostate cancer detection and localization. J Magn Reson Imaging 22:639-646
22. Futterer JJ, Heijmink SW, Scheenen TW et al (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241:449-458
23. Akin O, Sala E, Moskowitz CS et al (2006) Transition zone prostate cancers: Features, detection, localization, and staging at endorectal MR imaging. Radiology 239:784-792
24. Rouviere O, Raudrant A, Ecochard R et al (2003) Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol 13:931-942
25. Naughton CK, Ornstein DK, Smith DS et al (2000) Pain and morbidity of transrectal ultrasound guided prostate biopsy: A prospective randomized trial of 6 versus 12 cores. J Urol 163:168-171
26. Beyersdorff D, Taupitz M, Winkelmann B et al (2002) Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: Value of MR imaging. Radiology 224:701-706
27. Perrotti M, Han KR, Epstein RE et al (1999) Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: A pilot study. J Urol 162:1314-1317
28. Lattouf JB, Grubb RL 3rd, Lee SJ et al (2007) Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer. BJU Int 99:1041-1046
29. Portalez D, Malavaud B, Herigault G et al (2004) Predicting prostate cancer with dynamic endorectal coil MR and proton spectroscopic MR imaging. J Radiol 85:1999-2004
30. Cirillo S, Petracchini M, Della Monica P et al (2008) Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours. Clin Radiol 63:871-879
31. Yuen JS, Thng CH, Tan PH et al (2004) Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 171:1482-1486
32. Shukla-Dave A, Hricak H, Eberhardt SC et al (2004) Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings-initial observations. Radiology 231:717-724
33. Futterer JJ, Engelbrecht MR, Jager GJ et al (2007) Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17:1055-1065
34. Puech PFJ, Ballereau C, Leroy X, Villers A, Lemaître L (2004) Etude comparative de l'IRM de prostate par voie suspubienne ou endorectale. J Radiol 85:1402
35. Futterer JJ, Heijmink SW, Scheenen TW et al (2006) Prostate cancer: local staging at 3-T endorectal MR imaging-early experience. Radiology 238:184-191
36. Heijmink SW, Futterer JJ, Hambrock T et al (2007) Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-comparison of image quality, localization, and staging performance. Radiology 244:184-195
37. Anastasiadis AG, Lichy MP, Nagele U et al (2006) MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50:738-748
38. Singh AK, Kruecker J, Xu S et al (2008) Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int 101:841-845
39. Heijmink SW, van Moerkerk H, Kiemeney LA et al (2006) A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer. Eur Radiol 16:927-938
40. Mitterberger M, Pinggera GM, Horninger W et al (2007) Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: Impact on Gleason score. J Urol 178:464-468
41. Remzi M, Dobrovits M, Reissigl A et al (2004) Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy? Eur Urol 46:451-456
42. Ito H, Kamoi K, Yokoyama K et al (2003) Visualization of prostate cancer using dynamic contrast-enhanced MRI: Comparison with transrectal power Doppler ultrasound. Br J Radiol 76:617-624
43. Konig K, Scheipers U, Pesavento A et al (2005) Initial experiences with real-time elastography guided biopsies of the prostate. J Urol 174:115-117
44. Souchon R, Rouviere O, Gelet A et al (2003) Visualisation of HIFU lesions using elastography of the human prostate in vivo: Preliminary results. Ultrasound Med Biol 29:1007-1015
45. Pallwein L, Mitterberger M, Gradl J et al (2007) Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer. Curr Opin Urol 17:39-47